Compare MDCX & FENG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MDCX | FENG |
|---|---|---|
| Founded | 2008 | 1998 |
| Country | United States | China |
| Employees | 12 | N/A |
| Industry | | Broadcasting |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.2M | 20.9M |
| IPO Year | N/A | 2011 |
| Metric | MDCX | FENG |
|---|---|---|
| Price | $0.48 | $1.79 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $23.50 | N/A |
| AVG Volume (30 Days) | ★ 8.6M | 5.5K |
| Earning Date | 05-11-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.37 | $1.28 |
| 52 Week High | $8.90 | $3.65 |
| Indicator | MDCX | FENG |
|---|---|---|
| Relative Strength Index (RSI) | 31.41 | 62.04 |
| Support Level | $0.37 | $1.72 |
| Resistance Level | $1.43 | $2.03 |
| Average True Range (ATR) | 0.11 | 0.05 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 14.69 | 79.17 |
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.
Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives revenue from China.